Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
SARC-F is a Weaker Predictor Compared to Muscle Strength and a Stronger Predictor Compared to Muscle Mass for Mortality and Hospitalization in Hemodialysis Patients
Turkish Journal of Nephrology · Ekim 2022
YÖKSİS Kayıtları
SARC-F is a Weaker Predictor Compared to Muscle Strength and a Stronger Predictor Compared to Muscle Mass for Mortality and Hospitalization in Hemodialysis Patients
Turkish Journal of Nephrology · 2022 ESCI
DOKTOR ÖĞRETİM ÜYESİ MUSLU KAZIM KÖREZ →
SARC-F is a Weaker Predictor Compared to Muscle Strength and a Stronger Predictor Compared to Muscle Mass for Mortality and Hospitalization in Hemodialysis Patients
Turkish Journal of Nephrology · 2022 ESCI
PROFESÖR ZEYNEP BIYIK →
SARC-F is a Weaker Predictor Compared to Muscle Strength
and a Stronger Predictor Compared to Muscle Mass for
Mortality and Hospitalization in Hemodialysis Patients
turkish journal of nephrology · 2022 ESCI
PROFESÖR YASEMİN COŞKUN YAVUZ →
Makale Bilgileri
DergiTurkish Journal of Nephrology
Yayın TarihiEkim 2022
Cilt / Sayfa31 · 314-320
Scopus ID2-s2.0-85142927524
Erişim🔓 Açık Erişim
Özet
Objective: It is known that muscle strength and muscle mass decrease in hemodialysis patients. We aimed to compare the effect of SARC-F (strength, assistance with walking, rising from a chair, climbing stairs, and falls) questionnaire with that of handgrip strength and skeletal muscle mass/body mass index on 1-year mortality and hospitalization in hemodialysis patients. Methods: SARC-F test was filled for 67 hemodialysis patients, muscle strength was evaluated with handgrip strength, muscle mass was evaluated by performing bioimpedance analysis, and skeletal muscle mass/body mass index was evaluated by using the formula. Results: The end of 1 year revealed that 12 of 67 patients (17.9%) died. Of the patients, 38 (56.7%) were hospitalized. The number of hospitalizations was in the range of 0-9. The length of hospitalization varied between 2 and 77 days. The patients with low handgrip strength had a 9.86 times higher mortality risk (odds ratio = 9.862, 95% CI = 1.190-81.707, P = .034) and had a 5.27 times higher risk of hospitalization (odds ratio = 5.273, 95% CI = 1.828-15.207, P = .002). The patients who had lower SARC-F had a 3.88 times higher risk of hospitalization (odds ratio = 3.882, 95% CI = 1.340-11.252, P = .012). A positive statistically significant correlation was found between the patients' hospitalization periods and SARC-F scores (Spearman's rho = 0.329, P = .007), and a negative statistically significant correlation was found between the patients' hospitalization periods and handgrip strength scores. The duration of hospitalization was found to be significantly longer in the patients who had low handgrip strength (19.38 ± 22.25). Conclusion: SARC-F appears to be a weaker parameter than handgrip strength and a stronger parameter than skeletal muscle mass/body mass index on hospitalization and mortality.
Yazarlar (10)
1
Yasemin Coşkun Yavuz
2
Zeynep Bıyık
3
M. K. Korez
ORCID: 0000-0001-9524-6115
4
Sedat Abusoglu
ORCID: 0000-0002-2984-0527
5
Nicat Ahmadli
6
Duygu Eryavuz
7
Elif Balevi Batur
ORCID: 0000-0001-8886-1144
8
Muhammet Cemal Kızılarslanoğlu
9
Serkan Yavuz
10
Lütfullah Altıntepe
Anahtar Kelimeler
Hemodialysis
muscle mass
muscle strength
SARC-F
sarcopenia
Kurumlar
Beyhekim Training and Research Hospital
Konya Turkey
Konya City Hospital
Konya Turkey
Necmettin Erbakan Üniversitesi
Meram Turkey
Selçuk Tip Fakültesi
Konya Turkey